Olema Pharmaceuticals Quarterly Cash Flow Statement
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.820.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Olema Pharmaceuticals free cash flow
In the quarter ended Jun 30, 2026, Olema Pharmaceuticals generated -$45.9 million of operating cash flow. That left free cash flow of -$45.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
Olema Pharmaceuticals cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -63.20M | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M | -33.57M | -34.55M | -30.38M | -30.97M | -26.77M | -21.50M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 102.00K | 119.00K | 187.00K | 43.00K | 132.00K | 128.00K | 116.00K | 95.00K | 94.00K | 88.00K | 88.00K | 90.00K |
| Stock-Based Compensation | 12.90M | 10.15M | 4.27M | 4.25M | 4.69M | 4.38M | 6.32M | 5.63M | 5.72M | 4.91M | 4.35M | 4.11M |
| Change in Working Capital | -1.83M | -3.08M | 1.31M | 2.74M | -1.11M | -3.76M | 619.00K | -1.82M | -3.27M | 6.55M | 892.00K | 462.00K |
| Operating Cash Flow | -45.90M | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.55M | -23.50M | -18.48M | -22.74M |
| Capital Expenditures | — | — | — | 0 | — | — | 0 | 0 | -6.00K | -153.00K | — | — |
| Investing Cash Flow | 40.84M | 4.53M | -162.18M | 17.27M | 34.23M | -45.08M | -114.42M | 45.92M | -4.88M | -20.14M | -30.91M | -25.44M |
| Financing Cash Flow | 1.11M | 45.70M | 213.55M | 41.00K | -2.52M | 222.00K | 244.30M | 92.00K | 15.61M | 8.82M | 523.00K | 130.63M |
| Net Change in Cash | -3.95M | 4.25M | 13.04M | -17.21M | 1.83M | -88.84M | 103.59M | 19.00M | -16.83M | -34.82M | -48.87M | 82.45M |
| Free Cash Flow | -45.90M | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.56M | -23.65M | -18.48M | -22.74M |
This table shows 12 quarterly periods of Olema Pharmaceuticals's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OLMA's reporting calendar. What is a cash flow statement?